Translational Medicine
Open Access
ISSN: 2161-1025
ISSN: 2161-1025
Matiullah Khan
National University of Singapore, Singapore
Dr Khan is a Senior Research Scientist and an Assistant Professor of department of Medicine at National University of Singapore. He obtained his Ph.D. in Oncology from Graduate School of Medicine, University of Tokyo, Japan, in 1999. Later he worked at RIKEN, the premier research institute of Japan, as a Post-Doctoral Fellow and as a Research Scientist. In 2003, he joined the Oncology Research Institute (ORI) of National University of Singapore as an independent investigator. While working at National University of Singapore, he identified and characterized the protein misfolding pathway as an important oncogenic mechanism in some subtypes of AML, Lung and Liver Cancer. His current research is focused on therapeutic targeting of protein misfolding pathway in AML, Lung and Liver Cancer.
Dr Khan is a Senior Research Scientist and an Assistant Professor of department of Medicine at National University of Singapore. He obtained his Ph.D. in Oncology from Graduate School of Medicine, University of Tokyo, Japan, in 1999. Later he worked at RIKEN, the premier research institute of Japan, as a Post-Doctoral Fellow and as a Research Scientist. In 2003, he joined the Oncology Research Institute (ORI) of National University of Singapore as an independent investigator. While working at National University of Singapore, he identified and characterized the protein misfolding pathway as an important oncogenic mechanism in some subtypes of AML, Lung and Liver Cancer. His current research is focused on therapeutic targeting of protein misfolding pathway in AML, Lung and Liver Cancer.